The Food and Drug Administration (FDA) may no longer approve the drug based on new safety evidence
If something promotes tissue repair or cell migration, shouldn't we worry about those signals reaching the wrong cells
Many may need to continue taking GLP-1 medications in order to maintain their weight loss and health goals The doses of medication may stay the same or may be reduced to find the lowest effective dose that maintains weight and health Lifestyle and behavioural changes in the maintenance phase are crucial Any reduction or stopping of GLP-1 medication should be done under medical supervision, gradually Monitor weight and appetite vigilantly Many people will find that they can use a reduced dose of GLP-1 medication once they have achieved their target BMI
Rare but serious side effects : These include pancreatitis or gallbladder disease, and any concerning symptoms should be discussed with your prescribing healthcare provider immediately
The projected uptake of GLP-1RAs in the geographies relevant to their business and how this may change under different scenarios
Several meta-analyses suggest a reduced incidence of gestational diabetes with this dosing strategy, but authors emphasize that evidence quality is moderate and that further large-scale randomized trials are needed before universal recommendations can be made.9 24 25 26 Psychiatric research (high-dose, limited evidence) Studies exploring inositol for panic disorder, obsessive-compulsive disorder, or depression have used much higher doses often 12,00018,000mg per day.35 36 37 While some small trials reported symptom improvement, results have been inconsistent, and these doses are far higher than those used for metabolic or reproductive purposes.38 Most reviews do not recommend high-dose inositol for mental health outside of clinical supervision.42 Across contexts, higher doses do not consistently produce stronger effects